Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.

JAMA Netw Open · 2018 · PMC6324375 · PMID 30646343

Europe PMC DOI

hedged sentence

0.2000

closest p · 4.0× alpha

0.2000

boldest claim

The sentences

did not reach statistical significanceP = .20not close (p > 0.1)

Among patients who had IgG levels within the reference range before rituximab use ( Figure 2 E), an increase in the rate of severe infections was observed following rituximab use, but the difference did not reach statistical significance (from 26.0% to 30.7%; P = .20).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.